Rectal Cancer Global Clinical Trials Review, H2, 2011 (Related Reports)

Rectal Cancer Global Clinical Trials Review, H2, 2011


December 31, 2011
135 Pages - SKU: GBDT6744648
License type:
Online Download      US $1,000.00
Global Site License      US $3,000.00
Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014 provides data on the Metastatic Breast Cancer clinical trial scenario. This report provides elemental  |  read more...
$2,500.00
Pontine Glioma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Pontine Glioma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Pontine Glioma Global Clinical Trials Review, H1, 2014 provides data on the Pontine Glioma clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014 provides data on the B-Cell Non-Hodgkin Lymphoma clinical trial scenario. This report provides elemental  |  read more...
$2,500.00
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant
4/14/2014 | published by: GBI Research
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant Summary GBI Research, the leading business intelligence provider, has released its latest research,‘Pancreatic Adenocarcinoma  |  read more...
$3,500.00
Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014 provides data on the Low-Grade Astrocytoma clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
Low-Grade Glioma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Low-Grade Glioma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Low-Grade Glioma Global Clinical Trials Review, H1, 2014 provides data on the Low-Grade Glioma clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
Lymphoblastic Lymphoma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Lymphoblastic Lymphoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Lymphoblastic Lymphoma Global Clinical Trials Review, H1, 2014 provides data on the Lymphoblastic Lymphoma clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
Malignant Ascites Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Malignant Ascites Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Malignant Ascites Global Clinical Trials Review, H1, 2014 provides data on the Malignant Ascites clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
Malignant Glioma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Malignant Glioma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Malignant Glioma Global Clinical Trials Review, H1, 2014 provides data on the Malignant Glioma clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth
4/14/2014 | published by: GBI Research
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth Summary The leading business intelligence provider GBI Research has released its latest research report,  |  read more...
$3,500.00